PET/CT imaging study for solid tumors
Part of Cancer clinical trials.
This study uses a special PET/CT scan to see how a new imaging agent (18F-FAPIBiotin) spreads in the body and how much radiation it gives off. It's for people with confirmed solid tumors to help make future imaging more accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor that has been confirmed by a tissue sample (biopsy)
- You are willing to sign a consent form agreeing to take part in the study
- You are not pregnant or breastfeeding
- You do not have severe liver or kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging agent called 68Ga-NI-FAPI to see how well it works in a PET scan for people with different types of solid tumors. The goal is to help doctors better see and understand tumors.
This study tests how useful a special PET/CT scan (called 68Ga-FAPI) is for people who may have or have been diagnosed with cancer. The scan may help doctors see cancer activity more clearly.
This study uses a special imaging agent that targets a protein called FAP found on many solid tumors. It helps doctors see tumors more clearly and stage them better. If you have a confirmed solid tumor and are able to undergo PET or SPECT/CT scans, this trial may help improve how your cancer is evaluated.
This study uses a special PET scan (FAPI-PET) during routine workup to help detect tumors and decide how far they may have spread. You may be able to take part if you need a staging or restaging scan and can safely complete the imaging.
This trial tests a new PET/CT scan that uses a special tracer (68Ga-FAPI-Biotin) to help detect and see various solid tumors. It may provide more detailed images to guide treatment decisions.
This trial uses a special PET scan (68Ga-DOTA-NI-FAPI04) to get clearer images of various solid tumors. It may help doctors see your cancer better and plan your treatment.
Hear when a new Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.